TNXP this will be way higher with a big catalyst of data for their Fibromyalgia drug phase 2b on June 11th, which we already know the data is positive, because they already spoke to FDA re: the data and are now enrolling on their phase 3 trials
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.